1. Cholinergic anthelmintics, including levamisole and pyrantel, are used for the control of nematode parasites. We have found that cholinergic anthelmintics are not a homogenous functional class of drugs. These anthelmintics select for different subtypes of acetylcholine- gated ion-channel receptors (nAChRs) in muscle of parasitic nematodes. The different nAChR subtypes are produced by varied combinations of five subunit proteins: each subunit may be produced by a different gene. We will exploit our advances with RNAi, quantitative motility studies, molecular pharmacology and patch-clamp to study the diversity and dynamic nature of nAChR subtypes of Brugia malayi: a parasite that causes lymphatic filariasis. This parasite is an excellent specific and general nematode parasite model. It is tractable to study with techniques that permit functional studies of genes that produce the different subunits of the nAChR subtypes involved in parasite neuromuscular transmission. 2. The classic cholinergic anthelmintic, levamisole, selectively activates muscle L-subytpe nAChRs, producing spastic contraction in parasitic nematodes. In Brugia adults, responses to levamisole decline over an hour, but responses to other cholinergic anthelmintics do not. Why is there this loss of anthelmintic effect (tachyphylaxis) and why is there a difference between cholinergic anthelmintics? Here we will identify the dynamic functions and interactions of different nAChR genes and a mechanistic explanation for anthelmintic tachyphylaxis. 3. Our approach in Aim #1 will be to characterize, molecularly and pharmacologically, the four or more nAChRs subtypes present on Brugia somatic muscle.
In Aim #2, we will identify the functions of nAChR subunit genes by using RNAi on Brugia adults to produce different phenotypes and to alter muscle responses to different cholinergic anthelmintics.
In Aim #3, we will test the hypothesis that populations of receptor subtypes are dynamic, compensating for the effects of anthelmintic exposure; we will determine how the L-subtype nAChRs behave during tachyphylaxis. 4. The proposal is innovative, using a combination of techniques for the study of functional properties of filarial nAChR ion-channels genes. To our knowledge, we are the only lab that has been able to combine these techniques successfully for the study of nematode parasites. 5. The overall impact, by an innovative combination of techniques, we will discover important new information on: ?the functional properties of filarial nAChR genes sensitive to anthelmintics; ?the dynamic nature of different receptor subtypes and; ?the loss of functional receptors and expression of genes associated with anthelmintic tachyphylaxis
Anthelmintics are used for the control of nematode parasites. We have found that cholinergic anthelmintics are not a homogenous functional class of drugs: these drugs select for different molecular subtypes of acetylcholine-gated ion-channel receptors (nAChRs) in parasitic nematodes; there is also a recovery from some of these anthelmintics despite continued application. Here we exploit the technical advances we have made for studying Brugia malayi. We will identify the functional properties of different nAChR subtypes and genes involved in neuromuscular transmission, and identify mechanistic explanations for the loss of anthelmintic effects (recovery/ tachyphylaxis).
|Zheng, Fudan; Du, Xiangwei; Chou, Tsung-Han et al. (2017) (S)-5-ethynyl-anabasine, a novel compound, is a more potent agonist than other nicotine alkaloids on the nematode Asu-ACR-16 receptor. Int J Parasitol Drugs Drug Resist 7:12-22|
|Zheng, Fudan; Robertson, Alan P; Abongwa, Melanie et al. (2016) The Ascaris suum nicotinic receptor, ACR-16, as a drug target: Four novel negative allosteric modulators from virtual screening. Int J Parasitol Drugs Drug Resist 6:60-73|
|Abongwa, Melanie; Buxton, Samuel K; Robertson, Alan P et al. (2016) Curiouser and Curiouser: The Macrocyclic Lactone, Abamectin, Is also a Potent Inhibitor of Pyrantel/Tribendimidine Nicotinic Acetylcholine Receptors of Gastro-Intestinal Worms. PLoS One 11:e0146854|
|Abongwa, Melanie; Buxton, Samuel K; Courtot, Elise et al. (2016) Pharmacological profile of Ascaris suum ACR-16, a new homomeric nicotinic acetylcholine receptor widely distributed in Ascaris tissues. Br J Pharmacol 173:2463-77|
|Martin, R J; Puttachary, S; Buxton, S K et al. (2015) The Conqueror Worm: recent advances with cholinergic anthelmintics and techniques excite research for better therapeutic drugs. J Helminthol 89:387-97|
|Martin, Richard J; Verma, Saurabh; Choudhary, Shivani et al. (2015) Anthelmintics: The best way to predict the future is to create it. Vet Parasitol 212:18-24|
|Robertson, Alan P; Puttachary, Sreekanth; Buxton, Samuel K et al. (2015) Tribendimidine: mode of action and nAChR subtype selectivity in Ascaris and Oesophagostomum. PLoS Negl Trop Dis 9:e0003495|
|Trailovi?, Saša M; Marjanovi?, Djordje S; Nedeljkovi? Trailovi?, Jelena et al. (2015) Interaction of carvacrol with the Ascaris suum nicotinic acetylcholine receptors and gamma-aminobutyric acid receptors, potential mechanism of antinematodal action. Parasitol Res 114:3059-68|
|McCoy, Ciaran J; Warnock, Neil D; Atkinson, Louise E et al. (2015) RNA interference in adult Ascaris suum--an opportunity for the development of a functional genomics platform that supports organism-, tissue- and cell-based biology in a nematode parasite. Int J Parasitol 45:673-8|
|Chehayeb, James F; Robertson, Alan P; Martin, Richard J et al. (2014) Proteomic analysis of adult Ascaris suum fluid compartments and secretory products. PLoS Negl Trop Dis 8:e2939|
Showing the most recent 10 out of 44 publications